Orasure (NASDAQ:OSUR) Q4 results ($M): Revenues: 50.2 (-3.5%); Molecular Collection Systems: 25.4 (-14.8%); Infectious Disease Testing: 13.6 (-3.5%); OraQuick: 13.0 (-5.1%).
Net income: 10.3 (+40.8%); EPS: 0.16 (+33.3%).
Q1 guidance: Revenues: $29.0M – 30.5M.
Previously: OraSure Technologies beats by $0.05, beats on revenue (Feb. 6)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.